Patents
Patents for C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619)
09/2011
09/22/2011US20110229724 High flow supramolecular compounds
09/22/2011US20110227053 Novel chrysene derivatives and organic electrical device using the same
09/22/2011CA2793299A1 Morpholinylquinazolines
09/22/2011CA2792473A1 A process for the preparation of highly pure ambrisentan
09/21/2011EP2366696A1 Process for producing 4-aminoquinazolines
09/21/2011EP1798222B1 Binuclear metal complex, metal complex dye, photoelectric transducer and photochemical battery
09/21/2011EP1003728B1 2-(3-(4-(2-t-Butyl-6-trifluoromethylpyrimidin-4-yl)piperazin-1-yl)propylmercapto)pyrimidin-4-ol-fumarate
09/21/2011CN102197029A Sulfoximine-substituted anilinopyrimidine derivatives as CDK inhibitors, the production thereof, and use as medicine
09/21/2011CN102190629A Method for preparing azoxystrobin from hydrocyanic acid in acrylonitrile waste gas
09/21/2011CN102190628A Preparation method of 5-fluoro-6-ethyl-4-hydroxypyrimidine intermediate and Voriconazole
09/21/2011CN101389612B 4-(3-benzoylaminophenyl)-6,7-dimethoxy-2- methylaminoquinazoline derivative
09/20/2011US8022248 3-[2-(3-Cyanophenoxy)-4-(trifluoromethyl)phenyl]propanoic acid;prostaglandin D2 inhibitor, orphan receptor CRTH2 antagonist; antiinflammatory, analgesic, antipyretic; respiratory system disorders: asthma and rhinitis; coupling amino/thio-phenyl derivatives with ester followed by hydrolysis to acid
09/20/2011US8022079 Methods of modulating PPAR gamma-type receptors
09/20/2011US8022078 Pyrimidine classical cannabinoid compounds and related methods of use
09/20/2011US8022071 Nitrogenous heterocyclic compounds
09/20/2011CA2476067C Carbonylamino-derivatives as novel inhibitors of histone deacetylase
09/20/2011CA2471943C .beta.-amyloid protein production-secretion inhibitors
09/20/2011CA2439415C Cathepsin cysteine protease inhibitors
09/15/2011WO2011112428A2 Arylvinylazacycloalkane compounds for constipation
09/15/2011WO2011110198A1 A process for making voriconazole
09/15/2011WO2011086584A3 Improved process for the preparation of amide intermediates and their use thereof
09/15/2011WO2011068403A3 Novel n-{3-ethynylphenylamino)-6,7-bis(2-methoxyethoxy)-4-quinazolinamjne salts
09/15/2011US20110224435 Process for preparation of amorphous lopinavir
09/15/2011US20110224432 Heteroaryl compounds and uses thereof
09/15/2011US20110224244 Adamantyl Benzamide Derivatives
09/15/2011US20110224198 Aryl methyl benzoquinazolinine m1 receptor positive allosteric modulators
09/15/2011US20110224155 Modulation of chemosensory receptors and ligands associated therewith
09/15/2011US20110224083 Uracil compounds and a herbicide comprising the same
09/15/2011US20110223093 Ionic liquid systems for carbon dioxide and sulfur dioxide removal
09/15/2011CA2792157A1 Arylvinylazacycloalkane compounds for constipation
09/14/2011EP2364297A1 Compounds, pharmaceutical composition and methods for use in treating metabolic disorders
09/14/2011EP2364089A1 Heterobicyclic sphingosine 1-phosphate analogs
09/14/2011EP2049501B1 Hydroxylated and methoxylated cyclopenta [d] pyrimidines as akt protein kinase inhibitors
09/14/2011EP1809288B1 Use of 1,4-bis (3-aminoalkyl) piperazine derivatives in the treatment of neurodegenerative diseases
09/14/2011EP1689387B1 Bicyclic inhibitors of mek and methods of synthesis thereof
09/14/2011EP1471915B1 2,4-pyrimidinediamine compounds and their uses
09/14/2011CN1642551B Inhibitors of histone deacetylase
09/14/2011CN102186831A Optically active difluoromethanesulfonanilide derivative and herbicide
09/14/2011CN102186822A Novel urea and thiourea derivatives
09/14/2011CN102186821A Pentacyclic liquid crystal compound having nitrogen-containing heterocyclic ring, liquid crystal composition, and liquid crystal display element
09/14/2011CN102180844A Gefitinib intermediate and preparation method of Gefitinib
09/14/2011CN102180839A Water-soluble trimethoprim derivative and preparation method thereof
09/14/2011CN101786997B Amino acid and pesticide coupling compound as well as preparation method and application thereof as pesticide
09/14/2011CN101723905B Synthesis method of 2-(2-(6-(2-cyano phenoxyl) pyridine-4-oxygroup) phenyl) methyl acetate
09/14/2011CN101190898B Preparation method for 1.3-dimethylbarbituric acid
09/13/2011US8017771 Process for preparing acyclic HCV protease inhibitors
09/13/2011US8017620 Dutpase inhibitors
09/13/2011US8017619 Compositions useful as inhibitors of protein kinases
09/13/2011US8017614 Arylindenopyrimidines compound and use as an adenosine A2a receptor antagonists
09/13/2011CA2639407C Pharmaceutical compositions comprising (e)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl]-(3r,5s)-3,5-dihydroxyhept-6-enoic acid or a pharmaceutically acceptable salt thereof
09/13/2011CA2441565C Bisarylamines as potassium channel openers
09/13/2011CA2396937C Amides, useful in the inhibition of il-8-induced chemotaxis of neutrophils
09/13/2011CA2309260C 2,4-substituted pyrimidines and their use in herbicidal compositions
09/09/2011WO2011108612A1 Photoelectric conversion element and photoelectrochemical cell
09/09/2011WO2011107608A1 Heterocyclic amides as rock inhibitors
09/09/2011WO2011107585A1 Morpholino substituted urea derivatives as mtor inhibitors
09/09/2011WO2011066147A3 Crystalline salt forms of a pyrimidin- 5 - yl acetic acid derivative
09/09/2011CA2791338A1 Heterocyclic amides as rock inhibitors
09/09/2011CA2790707A1 Fluorouracil derivatives
09/08/2011US20110218330 Novel triazolo pyrimidine compounds
09/08/2011US20110218210 Compounds for treating abnormal cellular proliferation
09/08/2011US20110218208 2-heterocyclylaminoalkyl-(p-quinone) derivatives for treatment of oxidative stress diseases
09/08/2011US20110218192 Inhibitors Of Beta-Secretase
09/08/2011US20110217300 Quinazolinone Compounds and Methods of Use Thereof
09/07/2011EP2363393A1 Compounds and compositions as hedgehog pathway modulators
09/07/2011EP2069315B1 Quinazolinone and isoquinolinone acetamide derivatives
09/07/2011EP2049500B1 Cyclopenta [d] pyrimidines as akt protein kinase inhibitors
09/07/2011EP1877383B1 Quinoline and quinoxaline derivatives as inhibitors of kinase enzymatic activity
09/07/2011EP1853568B1 Hiv inhibiting 2-(4-cyanophenylamino)pyrimidine derivatives
09/07/2011CN1914182B Quinazoline derivatives
09/07/2011CN102174025A Isotope labeling reagent as well as preparation method and application thereof
09/07/2011CN102174024A 2,4-pyrimidinediamine compounds and their uses
09/07/2011CN102174023A Preparation method of hydroxyl pyridine compound
09/07/2011CN101213180B Method for producing dihydroquinazolines
09/06/2011US8013160 Fluorene-based derivative and organic electroluminescence device employing the same
09/06/2011US8013155 Method for preparing substituted pyrimidines
09/06/2011US8013154 Insecticidal substituted azinyl derivatives
09/06/2011US8013045 Monoazo colorants for mass-colouring of polymers
09/06/2011US8013015 Small molecule inhibitors of ghrelin O-acyltransferase
09/06/2011US8012991 3-(2,4-dimethoxyphenyl)-1,9-dimethyl-2-oxo-2,9-dihydro-1H-pyrido[2,3-b]indole-6-carboxylic acid; gamma-aminobutyric acid modulator; anticarcinogenic, antitumor, antiproliferative agent; amidating a 2-aminoindole with an alpha-substituted-beta-hydroxy-alkyl acrylate
09/06/2011US8012988 N-(2,4-dioxo-6-(tetrahydrofuran-2-yl)-7-(trifluoromethyl)-1,4-dihydro-2H-quinazolin-3-yl)methanesulfonamide
09/06/2011US8012959 Diaminopyrimidinecarboxamide derivative
09/06/2011US8012602 Blue emitting, durable, organoelectroluminescent layers containing pyrimidine moieties; full color displays; light emission efficiency and brightness
09/06/2011CA2493785C Pyrimidyl sulphone amide derivatives as chemokine receptor modulators
09/06/2011CA2373360C Carboxylic acid derivatives that inhibit the binding of integrins to their receptors
09/01/2011WO2011105572A1 Novel heteroaryl derivative
09/01/2011WO2011104725A2 Hmg-coa reductase inhibitors and process for the preparation thereof
09/01/2011WO2011104203A1 Compounds as bradykinin b1 antagonists
09/01/2011US20110213148 Co-crystal compound of optical device
09/01/2011US20110212983 Platelet adp receptor inhibitors
09/01/2011US20110212969 Substituted hydroxamic acids and uses thereof
09/01/2011US20110212945 Azabiphenylaminobenzoic acid derivatives as dhodh inhibitors
09/01/2011US20110212937 Compounds for the reduction of beta-amyloid production
09/01/2011CA2790952A1 Compounds as bradykinin b1 antagonists
08/2011
08/31/2011EP2361908A1 Pyrimidine compounds useful for the treatment of CNS diseases
08/31/2011EP2361906A1 Process for preparing rosuvastatin
08/31/2011EP2361248A1 Heteroaryl compounds and uses thereof
08/31/2011EP2215054B1 Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same
08/31/2011EP2205571B1 Phenobarbital derivatives useful in immunoassay
08/31/2011EP2173723B1 Pyrimidyl cyclopentanes as akt protein kinase inhibitors
1 ... 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 ... 427